
Opinion|Videos|September 23, 2024
Considerations for Dose Modifications
The discussion addresses when dose modifications are typically required in chronic lymphocytic leukemia treatment and identifies the most common reasons for these modifications.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- When do patients typically require dose modification in chronic lymphocytic leukemia (CLL) treatment, and what are the most common reasons for dose modifications in CLL treatments?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Paradigm Shift in Lipid Management: Highlights from the NLA 2026 Scientific Sessions Opening Session
2
ATTR-CM Red Flags, Treatment Evidence, and the Pharmacist's Role in Care
3
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant Treatment of High-Risk Clear Cell RCC
4
Final CLL14 Analysis Confirms Durable Benefit With Fixed-Duration Venetoclax-Obinutuzumab in Frontline CLL
5






























































































































